Lose 14-15% of your body weight* *In clinical trials of Wegovy (FDA-approved semaglutide), participants achieved an average weight loss of approximately 15% over 68 weeks, with some participants achieving up to 20% with continued treatment and adherence, when combined with diet and exercise
Gut Lining & Ulcer Healing: Only BPC-157 has strong GI-focused evidence
Conclusion When used thoughtfully, copper peptides for collagen, and GHK-Cu in particular, offer a targeted way to support smoother skin, improved firmness, and healthier-looking hair
Injectable GHK-Cu is a separate matter: not FDA-approved, placed in FDA 503A Category 2 for injectable use, and not something to assume is safe
Mechanism involves NO system modulation (homeostatic regulationupregulating when deficient, moderating when excessive), VEGF/VEGFR2 upregulation for angiogenesis, FAK-paxillin pathway activation for cell migration (40% increase per Chang et al.), and EGR-1 transcription factor upregulation for growth factor sensitivity